TickerFactsScreenerDevelopers

Mirum Pharmaceuticals, Inc. (MIRM) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2018: $51.96M2019: $11.97M2020: $142.09M2021: $31.34M2022: $28.00M2023: $286.33M2024: $222.50M2025: $296.68M$296.68M
2018Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$296.68M+33.3%
2024$222.50M-22.3%
2023$286.33M+922.5%
2022$28.00M-10.6%
2021$31.34M-77.9%
2020$142.09M+1087.0%
2019$11.97M-77.0%
2018$51.96M—